These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1530955

  • 1. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
    Madi N, Steiger G, Estreicher J, Schifferli JA.
    J Immunol; 1992 Feb 01; 148(3):723-8. PubMed ID: 1530955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
    Schifferli JA, Ng YC, Estreicher J, Walport MJ.
    J Immunol; 1988 Feb 01; 140(3):899-904. PubMed ID: 2963069
    [Abstract] [Full Text] [Related]

  • 4. Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.
    Madi N, Paccaud JP, Steiger G, Schifferli JA.
    Clin Exp Immunol; 1989 Nov 01; 78(2):201-6. PubMed ID: 12412749
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
    Jouvin MH, Rozenbaum W, Russo R, Kazatchkine MD.
    AIDS; 1987 Jul 01; 1(2):89-94. PubMed ID: 2966632
    [Abstract] [Full Text] [Related]

  • 6. Splenic uptake of immune complexes in man is complement-dependent.
    Davies KA, Erlendsson K, Beynon HL, Peters AM, Steinsson K, Valdimarsson H, Walport MJ.
    J Immunol; 1993 Oct 01; 151(7):3866-73. PubMed ID: 8376807
    [Abstract] [Full Text] [Related]

  • 7. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP, Carpentier JL, Schifferli JA.
    Eur J Immunol; 1990 Feb 01; 20(2):283-9. PubMed ID: 2138082
    [Abstract] [Full Text] [Related]

  • 8. A study of in vivo immune complex formation and clearance in man.
    Davies KA, Hird V, Stewart S, Sivolapenko GB, Jose P, Epenetos AA, Walport MJ.
    J Immunol; 1990 Jun 15; 144(12):4613-20. PubMed ID: 2141040
    [Abstract] [Full Text] [Related]

  • 9. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W, Burdick G, Carl V, Lachmann PJ.
    J Immunol; 1989 Jun 15; 142(12):4366-71. PubMed ID: 2524529
    [Abstract] [Full Text] [Related]

  • 10. Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II.
    Madi N, Steiger G, Estreicher J, Schifferli JA.
    J Immunol; 1991 Jul 15; 147(2):495-502. PubMed ID: 2071892
    [Abstract] [Full Text] [Related]

  • 11. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).
    Madi N, Steiger G, Estreicher J, Schifferli JA.
    Clin Exp Immunol; 1991 Sep 15; 85(3):373-8. PubMed ID: 1893616
    [Abstract] [Full Text] [Related]

  • 12. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM.
    J Autoimmun; 2005 Dec 15; 25(4):289-97. PubMed ID: 16289666
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.
    Paccaud JP, Carpentier JL, Schifferli JA.
    J Immunol; 1988 Dec 01; 141(11):3889-94. PubMed ID: 2972779
    [Abstract] [Full Text] [Related]

  • 15. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep 01; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 16. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N, Paccaud JP, Steiger G, Schifferli JA.
    Clin Exp Immunol; 1991 Apr 01; 84(1):9-15. PubMed ID: 1826650
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
    Beynon HL, Davies KA, Haskard DO, Walport MJ.
    J Immunol; 1994 Oct 01; 153(7):3160-7. PubMed ID: 8089493
    [Abstract] [Full Text] [Related]

  • 19. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC, Wright E, Taylor RP.
    J Immunol; 1987 Dec 01; 139(11):3739-47. PubMed ID: 2960742
    [Abstract] [Full Text] [Related]

  • 20. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
    Taylor RP, Wright EL, Pocanic F.
    J Immunol; 1989 Dec 01; 143(11):3626-31. PubMed ID: 2584711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.